Treatments for asthma, chronic rhinosinusitis with nasal polyps, dyslipidemia, Cushing syndrome, gonorrhea, HSCT-associated thrombotic microangiopathy, marginal zone lymphoma, motion sickness, ...

The FDA has approved Rybelsus® to reduce the risk of MACE in adults with T2DM who are at high risk for these events.

Investing.com -- Ironwood Pharmaceuticals (NASDAQ:IRWD) stock rose 8% after the U.S. Food and Drug Administration (FDA) approved the company’s Linzess (linaclotide) capsules for pediatric patients 7 ...

The FDA's streamlined approval processes, including updated 510(k) and De Novo pathways and innovative programs like the Breakthrough Device and Safer Technologies Programs, present opportunities for ...

The FDA announced that it will relax certain rules for approving low-cost versions of some high-priced medications.

Lifileucel shows a 25.6% objective response rate and 71.8% disease control rate in advanced nonsquamous NSCLC patients, ...

The FDA plans to eliminate comparative clinical study requirements that currently add $24 million and up to eight years to ...

By Siddhi Mahatole (Reuters) -Shares of Biohaven fell more than 40% on Wednesday after the U.S. Food and Drug Administration declined to approve its experimental treatment for a rare brain disorder. T ...

Is Galleri the future of cancer treatment? It's not that simple. The new research from the company, while promising, isn't ...